Targeted and armed oncolytic adenovirus via chemoselective modification

被引:11
作者
Banerjee, Partha S.
Zuniga, Edison S.
Ojima, Iwao
Carrico, Isaac S.
机构
[1] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11790 USA
[2] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11790 USA
关键词
Non-canonical; Unnatural; Chemoselective; Click; Staudinger; Adenovirus; Taxoid; Paclitaxel; Oncolytic; Gene delivery; HERPES-SIMPLEX-VIRUS; CANCER; EFFICACY; PACLITAXEL; PROTEINS; DELIVERY; CELLS;
D O I
10.1016/j.bmcl.2011.05.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Oncolytic adenoviruses (Ads) are an emerging alternative therapy for cancer; however, clinical trial have not yet demonstrated sufficient efficacy. When oncolytic Ads are used in combination with taxoids a synergistic increase in both cytotoxicity and viral replication is observed. In order to generate a next generation oncolytic adenovirus, virion were physically conjugated to a highly potent taxoid, SB-T-1214, and a folate targeting motif. Conjugation was enabled via the metabolic incorporation of non-canonical monosaccharides (O-GlcNAz) and amino acids (homopropargylglycine), which served as sites for chemoselective modification. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4985 / 4988
页数:4
相关论文
共 28 条
  • [1] Chemoselective Attachment of Small Molecule Effector Functionality to Human Adenoviruses Facilitates Gene Delivery to Cancer Cells
    Banerjee, Partha Sarathi
    Ostapchuk, Philomena
    Hearing, Patrick
    Carrico, Isaac
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (39) : 13615 - 13617
  • [2] New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells
    Botchkina, Galina I.
    Zuniga, Edison S.
    Das, Manisha
    Wang, Yuan
    Wang, Hichao
    Zhu, Shu
    Savitt, Anne G.
    Rowehl, Rebecca A.
    Leyfman, Yan
    Ju, Jingfang
    Shroyer, Kenneth
    Ojima, Iwao
    [J]. MOLECULAR CANCER, 2010, 9
  • [3] Metabolic cross-talk allows labeling of O-linked β-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway
    Boyce, Michael
    Carrico, Isaac S.
    Ganguli, Anjali S.
    Yu, Seok-Ho
    Hangauer, Matthew J.
    Hubbard, Sarah C.
    Kohler, Jennifer J.
    Bertozzi, Carolyn R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (08) : 3141 - 3146
  • [4] Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug Release
    Chen, Shuyi
    Zhao, Xianrui
    Chen, Jingyi
    Chen, Jin
    Kuznetsova, Larisa
    Wong, Stanislaus S.
    Ojima, Iwao
    [J]. BIOCONJUGATE CHEMISTRY, 2010, 21 (05) : 979 - 987
  • [5] E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models
    Cheong, S. C.
    Wang, Y.
    Meng, J-H
    Hill, R.
    Sweeney, K.
    Kirn, D.
    Lemoine, N. R.
    Hallden, G.
    [J]. CANCER GENE THERAPY, 2008, 15 (01) : 40 - 50
  • [6] Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells
    Hassan, M. A. I. AbouEl
    Braam, S. R.
    Kruyt, F. A. E.
    [J]. CANCER GENE THERAPY, 2006, 13 (12) : 1105 - 1114
  • [7] Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1
    Huang, B.
    Sikorski, R.
    Kirn, D. H.
    Thorne, S. H.
    [J]. GENE THERAPY, 2011, 18 (02) : 164 - 172
  • [8] Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species
    Jogler, C
    Hoffmann, D
    Theegarten, D
    Grunwald, T
    Überla, K
    Wildner, O
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (07) : 3549 - 3558
  • [9] Residue-specific incorporation of non-canonical amino acids into proteins: recent developments and applications
    Johnson, Jeremiah A.
    Lu, Ying Y.
    Van Deventer, James A.
    Tirrell, David A.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (06) : 774 - 780
  • [10] Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents
    Kuznetsova, L
    Chen, J
    Sun, L
    Wu, XY
    Pepe, A
    Veith, JA
    Pera, P
    Bernacki, RJ
    Ojima, I
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (04) : 974 - 977